Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines
<p>Abstract</p> <p>Venous thromboembolism (VTE) is an important cause of avoidable morbidity and mortality. However, routine prophylaxis for at-risk patients is underused. Recent guidelines issued by an international consensus group, including the International Union of Angiology (...
Hlavní autor: | Prandoni Paolo |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
BMC
2008-09-01
|
Edice: | Thrombosis Journal |
On-line přístup: | http://www.thrombosisjournal.com/content/6/1/13 |
Podobné jednotky
-
Low-molecular-weight heparins in the treatment of venous thromboembolism
Autor: Huisman Menno V, a další
Vydáno: (2000-08-01) -
Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients
Autor: N. V. Vorobyev, a další
Vydáno: (2018-11-01) -
Primary prevention of venous thromboembolism with low molecular weight heparins in surgical patients – 2024: Council of Experts resolution
Autor: А. S. Petrikov, a další
Vydáno: (2024-08-01) -
Low molecular weight heparin in one or two doses for the initial treatment of venous thromboembolic disease?
Autor: Juan Pablo Albornoz, a další
Vydáno: (2015-12-01) -
Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins
Autor: Alannah Smrke, a další
Vydáno: (2017-08-01)